SEC Form 4 · accession 0000899866-16-000310
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard Bell
Director
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | May 11, 2016 | A | 835 | $0.00 | A | 406,299 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $138.86 | May 11, 2016 | A | 2,294 | A | May 11, 2017 | May 11, 2026 | Common Stock, par value $.0001 per share | 2,294 | 2,294 | D |
Explanation of responses
- F1Award of Restricted Stock Units under 2004 Incentive Plan. 100% vests on the first anniversary of the grant date.
- F2Annual award of stock options under 2004 Incentive Plan. 100% vests on the first anniversary of the grant date.